Antibiotic treatment recommendations for acute respiratory tract infections in Scandinavian general practices-time
Malene Plejdrup Hansen1,2, Sigurd Høye3, Katarina Hedin4,5,6
1Center for General Practice, Aalborg University, Aalborg, Denmark.
Introduction:
During recent years, the world-including Scandinavia-has experienced significant challenges with shortages of antibiotics. In Scandinavia, phenoxymethylpenicillin is recommended as first-line antibiotic treatment for most acute respiratory tract infections (ARTIs). However, the Scandinavian countries each constitute rather small markets for phenoxymethylpenicillin. The aim of this discussion paper is to enlighten the differences in Scandinavian ARTI antibiotic treatment recommendations. This information is fundamental for exploring the potential of harmonizing treatment recommendations in Denmark, Norway and Sweden-to help ensure sufficient future supply of phenoxymethylpenicillin.
Methods:
Information from national ARTI antibiotic treatment recommendations from respectively Denmark, Norway and Sweden has been collated.
Results:
Several discrepancies exist in recommendations. Adult dosage varies from a minimum of 660 mg x 4 (Denmark) to a maximum of 2000 mg × 3 (Sweden). Within Norway and Sweden, variations in recommended dosage also exist between the different types of ARTIs. A main challenge is that the tablet strengths recommended, and available on the market in the three countries, differs.Also, antibiotic treatment durations vary significantly between countries and infections treated-from five to 10 days of treatment.
Conclusion:
In the capacity of a well-established network for antibiotic stewardship, we have enlightened the differences in Scandinavian ARTI antibiotic treatment recommendations. This paper is the first step moving forward to scrutinizing the potential for harmonizing recommendations for Denmark, Norway and Sweden-to help ensure continued supply of phenoxymethylpenicillin for use within the Scandinavian countries.
Insights
Scandinavian countries face antibiotic shortages, particularly for phenoxymethylpenicillin used in acute respiratory tract infections (ARTIs). Differences in ARTI treatment recommendations across Denmark, Norway, and Sweden hinder supply harmonization efforts.
Area of Science:
- Pharmacology
- Infectious Diseases
- Public Health
Background:
- Global antibiotic shortages pose significant challenges, impacting Scandinavia.
- Phenoxymethylpenicillin is a key treatment for acute respiratory tract infections (ARTIs) in Scandinavia.
- Small market sizes in Scandinavian countries may affect phenoxymethylpenicillin supply.
Purpose of the Study:
- To analyze and compare ARTI antibiotic treatment recommendations in Denmark, Norway, and Sweden.
- To identify discrepancies in treatment guidelines across these Scandinavian nations.
- To lay the groundwork for harmonizing recommendations and ensuring phenoxymethylpenicillin supply.
Main Methods:
- Collated national ARTI antibiotic treatment recommendations from Denmark, Norway, and Sweden.
- Comparative analysis of dosage, tablet strengths, and treatment durations.
Main Results:
- Significant discrepancies found in adult dosage recommendations (660 mg x 4 in Denmark to 2000 mg x 3 in Sweden).
- Variations in recommended dosage and treatment durations (5-10 days) exist between countries and infection types.
- Differences in recommended and available tablet strengths present a challenge.
Conclusions:
- Disparities in ARTI treatment guidelines across Scandinavia are evident.
- Harmonizing these recommendations is a crucial step towards ensuring a stable phenoxymethylpenicillin supply.
- This study initiates the process of scrutinizing potential harmonization for improved antibiotic availability.
Related Concept Videos
01:26Tonsillitis II: Management
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...